hydroxyproline has been researched along with metallothionein in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (20.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Nagai, Y; Sasaki, M; Sato, M | 1 |
Cabré, M; Camps, J; del Castillo, D; Ferré, N; Folch, J; Hernàndez, M; Joven, J; Paternain, JL | 1 |
Helal, GK; Helal, OK | 1 |
Domitrović, R; Jakovac, H; Sain, I; Tomac, J | 1 |
Al-Ismaeel, H; Al-Rikabi, AC; Al-Shabanah, OA; Mansour, MA | 1 |
5 other study(ies) available for hydroxyproline and metallothionein
Article | Year |
---|---|
Increased urinary excretion of collagen metabolites in cadmium-metallothionein nephropathy.
Topics: Acute Kidney Injury; Animals; Cadmium; Female; Hydroxylysine; Hydroxyproline; Metallothionein; Mice; Rats; Rats, Inbred Strains | 1987 |
Inhibition of hepatic cell nuclear DNA fragmentation by zinc in carbon tetrachloride-treated rats.
Topics: Animals; Carbon Tetrachloride; DNA Fragmentation; Hydroxyproline; Liver; Liver Cirrhosis, Experimental; Male; Metallothionein; Rats; Rats, Wistar; Zinc | 1999 |
Metallothionein attenuates carmustine-induced oxidative stress and protects against pulmonary fibrosis in rats.
Topics: Animals; Antineoplastic Agents, Alkylating; Carmustine; Collagen; Glutathione; Glutathione Reductase; Hydroxyproline; Injections, Intraperitoneal; Lung; Male; Metallothionein; Oxidative Stress; Pulmonary Fibrosis; Random Allocation; Rats; Rats, Wistar; Tumor Necrosis Factor-alpha | 2009 |
Liver fibrosis in mice induced by carbon tetrachloride and its reversion by luteolin.
Topics: Actins; Animals; Carbon Tetrachloride Poisoning; Chemical and Drug Induced Liver Injury; Copper; Expectorants; Glial Fibrillary Acidic Protein; Glutathione; Hydroxyproline; Immunohistochemistry; Liver; Liver Cirrhosis; Luteolin; Male; Matrix Metalloproteinases; Metallothionein; Mice; Mice, Inbred BALB C; Superoxide Dismutase; Vitamin A; Zinc | 2009 |
Comparison of angiotensin converting enzyme inhibitors and angiotensin II type 1 receptor blockade for the prevention of premalignant changes in the liver.
Topics: alpha-Fetoproteins; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Anticarcinogenic Agents; Captopril; Carcinoembryonic Antigen; Endostatins; Enzyme-Linked Immunosorbent Assay; Fibroblast Growth Factors; Hydroxyproline; Liver; Liver Neoplasms, Experimental; Losartan; Male; Matrix Metalloproteinase 2; Metallothionein; Perindopril; Precancerous Conditions; Rats; Transforming Growth Factor beta1; Vascular Endothelial Growth Factor A | 2011 |